Jennifer R. Stratton-Thomas
- Cancer Research top 10%
- Molecular Biology
- Hematology top 10%
- Oncology
- Immunology and Allergy top 10%
- Co-authors
- H Y MinSusan M. RosenbergC R VittMarc A. ShumanCatherine ZandonellaLaura V. DoylePatricia Tekamp-OlsonSteven Rosenberg
- Topics
- Protease and Inhibitor Mechanisms (3 papers)HER2/EGFR in Cancer Research (1 paper)Glycosylation and Glycoproteins Research (1 paper)
- Journals
- BiochemistryProtein Engineering Design and SelectionFibrinolysis & proteolysis
- Partner nations
- Japan
In The Last Decade
Jennifer R. Stratton-Thomas
6 papers receiving 326 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 197
- Molecular Biology 159
- Hematology 91
- Oncology 85
- Immunology and Allergy 77
Countries citing papers authored by Jennifer R. Stratton-Thomas
This map shows the geographic impact of Jennifer R. Stratton-Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer R. Stratton-Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer R. Stratton-Thomas more than expected).
Fields of papers citing papers by Jennifer R. Stratton-Thomas
This network shows the impact of papers produced by Jennifer R. Stratton-Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer R. Stratton-Thomas. The network helps show where Jennifer R. Stratton-Thomas may publish in the future.
Co-authorship network of co-authors of Jennifer R. Stratton-Thomas
This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer R. Stratton-Thomas. A scholar is included among the top collaborators of Jennifer R. Stratton-Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer R. Stratton-Thomas. Jennifer R. Stratton-Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 2 | |
| 3 | Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. | 218 |
| 4 | 19 | |
| 5 | Two distinct human endothelin B receptors generated by alternative splicing from a single gene. | 50 |
| 6 | 50 |
About Jennifer R. Stratton-Thomas
Jennifer R. Stratton-Thomas is a scholar working on Cancer Research, Hepatology and Cell Biology, having authored 6 papers that have together received 348 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (3 papers), HER2/EGFR in Cancer Research (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Cancer Research (197 citations), Immunology and Allergy (77 citations) and Hematology (91 citations). Jennifer R. Stratton-Thomas has collaborated with scholars based in Japan. Frequent co-authors include H Y Min, Susan M. Rosenberg, C R Vitt, Marc A. Shuman, Catherine Zandonella, Laura V. Doyle, Patricia Tekamp-Olson, Steven Rosenberg, Bruce A. Malcolm and Robert Ralston. Their work appears in journals such as Biochemistry, Protein Engineering Design and Selection and Fibrinolysis & proteolysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.